Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chronic Plaque Psoriasis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chronic Iron Overload | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chronic Intermittent Intravenous Insulin Therapy (CIIIT) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chronic Hepatitis C (HCV) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chromoendoscopy as an Adjunct to Colonoscopy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chemical Peels | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Chelation Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Charged-Particle (Proton or Helium Ion) Radiotherapy for Neoplastic Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cervical Cancer Screening Technologies with Pap and HPV | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cellular Immunotherapy for Prostate Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Catheter Ablation as Treatment for Atrial Fibrillation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Carrier Screening for Genetic Diseases | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cardiac Rehabilitation in the Outpatient Setting | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cardiac Hemodynamic Monitoring for the Management of Heart Failure in the Outpatient Setting | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cardiac Computed Tomographic Angiography (CCTA) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cardiac Applications of PET Scanning | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cablivi (caplacizumab-yhdp) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Cabenuva (cabotegravir and rilpivirine) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | CA-125 | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Buprenorphine | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bronchial Valves | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bronchial Thermoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Brineura (cerliponase alfa) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Breast Reconstruction Following Mastectomy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Breast Elastography | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Brachytherapy for Clinically Localized Prostate Cancer Using Permanently Implanted Seeds | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Botulinum Toxin | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bone Morphogenetic Protein | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bone Mineral Density Studies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Blepharoplasty | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Biventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Biosimilar Medications | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bioimpedance Devices for Detection and Management of Lymphedema | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Biofeedback as a Treatment of Urinary Incontinence in Adults | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Biofeedback | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Bioengineered Skin and Soft Tissue Substitutes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | BCR-ABL1 Testing in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Baroreflex Stimulation Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the Shoulder | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Balloon Ostial Dilation for Treatment of Chronic and Recurrent Acute Rhinosinusitis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Balloon Dilation of the Eustachian Tube | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | B-Natriuretic Peptide | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Axillary Reverse Mapping for Prevention of Breast Cancer-Related Lymphedema | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Axial Lumbosacral Interbody Fusion | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Autonomic Nervous System Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | AutoMove AM800 | New policy |